US 12240833
Pyridazinone compounds and uses thereof
granted A61PA61P21/00
Quick answer
US patent 12240833 (Pyridazinone compounds and uses thereof) held by EDGEWISE THERAPEUTICS, INC. expires Mon Feb 27 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- EDGEWISE THERAPEUTICS, INC.
- Grant date
- Tue Mar 04 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 27 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 28
- CPC classes
- A61P, A61P21/00